We are live on ! Find out more
SVNT

SAVIENT PHARMACEUTICALS INC
SVNT

Delisted

SVNT was delisted on the 16th of October, 2013.

3 hedge funds and large institutions have $231K invested in SAVIENT PHARMACEUTICALS INC in 2015 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

23,000% more capital invested

Capital invested by funds: $1K → $231K (+$230K)

0% more funds holding

Funds holding: 33 (0)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
FIM
Freedom Investment Management
Connecticut
-$757K
Name Holding Trade Value Shares
Change
Change in
Stake
FIM
1
Freedom Investment Management
Connecticut
$230K -$757K -10,491 -77%
PSC
2
Prentiss Smith & Co
Vermont
$1K

SVNT Hedge Fund Activity: Q3 2015 in Review

3 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in SAVIENT PHARMACEUTICALS INC (SVNT) for Q3 2015, worth a combined $231K — up 23,000% from $1K a quarter earlier.

Fund positioning in SVNT was balanced in Q3 2015: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Freedom Investment Management, cutting an estimated $757K.

  • 3 institutional investors held SAVIENT PHARMACEUTICALS INC (SVNT) as of Q3 2015, unchanged from Q2 2015.
  • Funds reported $231K of SAVIENT PHARMACEUTICALS INC stock for Q3 2015, up 23,000% quarter-over-quarter.
  • 0 funds opened new SAVIENT PHARMACEUTICALS INC positions in Q3 2015 and 0 closed out.
  • The largest SAVIENT PHARMACEUTICALS INC seller in Q3 2015 was Freedom Investment Management, an estimated $757K sold.

Based on aggregated 13F filings for Q3 2015.